Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
176.6 INR | -2.86% | +4.10% | +9.28% |
15/02 | Fermenta Biotech Sells Premises in Thane, India for INR136 Million | MT |
12/02 | Fermenta Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
Sales 2022 | 3.99B 47.8M | Sales 2023 | 3.5B 41.97M | Capitalization | 3.09B 37M |
---|---|---|---|---|---|
Net income 2022 | 154M 1.85M | Net income 2023 | -515M -6.18M | EV / Sales 2022 | 2.02 x |
Net Debt 2022 | 2.13B 25.59M | Net Debt 2023 | 1.6B 19.15M | EV / Sales 2023 | 1.34 x |
P/E ratio 2022 |
38.6
x | P/E ratio 2023 |
-5.99
x | Employees | 550 |
Yield 2022 |
0.61% | Yield 2023 |
1.17% | Free-Float | 25.21% |
1 day | -2.86% | ||
1 week | +4.10% | ||
Current month | +16.64% | ||
1 month | +20.14% | ||
3 months | +13.97% | ||
6 months | -0.98% | ||
Current year | +9.28% |
Managers | Title | Age | Since |
---|---|---|---|
Prashant Nagre
CEO | Chief Executive Officer | 54 | 06/21/06 |
Sumesh Gandhi
DFI | Director of Finance/CFO | - | 16/17/16 |
Compliance Officer | - | 12/02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 83 | 17/19/17 | |
Director/Board Member | 54 | 12/22/12 | |
Director/Board Member | 42 | 03/01/03 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 176.6 | -2.86% | 14,695 |
25/24/25 | 181.8 | -0.66% | 11,408 |
24/24/24 | 183 | +3.24% | 28,613 |
23/24/23 | 177.2 | +2.84% | 22,554 |
22/24/22 | 172.4 | +1.59% | 11,107 |
Delayed Quote Bombay S.E., April 26, 2024 at 03:30 pm IST
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.28% | 61.14M | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.36B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- FERMENTA Stock